US Patent Issued to NEOGENE THERAPEUTICS on Dec. 9 for "Methods to enrich genetically engineered T cells" (Dutch Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,386, issued on Dec. 9, was assigned to NEOGENE THERAPEUTICS B.V. (Amsterdam).

"Methods to enrich genetically engineered T cells" was invented by Carsten Linnemann (Amsterdam), Thomas Kuilman (Amstelveen, Netherlands), Gavin M. Bendle (Amsterdam), Jeroen W.J. van Heijst (Amstelveen, Netherlands) and Xiangjun Kong (Amsterdam).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various embodiments are disclosed herein relate to methods for selection of a genetically engineered cell. Some embodiments relate to a cell that is produced with the methods disclosed herein."

The patent was filed on Aug. 5, 2021, under Application No. 17/395,132.

*For further infor...